LonTalk, a system networking protocol from the 1990s, is buried deep in many internet-connected building systems, creating ...
Our new patent-pending BMS has been released on our first two models Z-Viper and Z-Python. Please visit our website for ...
The FDA has started a priority review of iberdomide as an add-on to Johnson & Johnson and Genmab's anti-CD38 antibody Darzalex (daratumumab) and dexamethasone, a standard regimen for relapsed or ...
[Editor’s note: The hacker requested that we remove the image for legal reasons, so it’s blurry now. We hope all’s well!] Lithium technology has ushered in a new era of batteries with exceptionally ...
The FDA has accepted Bristol Myers Squibb (BMS)’s New Drug Application (NDA) for iberdomide for relapsed or refractory ...
Supreme Court declines to stay Zydus Lifesciences' launch of biosimilar nivolumab, asks BMS to seek interim relief before ...
Indian Institute of Technology Roorkee has signed a Memorandum of Understanding (MoU) with MaxVolt Energy to collaborate on ...
Bristol Myers Squibb (BMS) plans to buy out its partner in developing the blockbuster multiple myeloma drug Abecma ® (idecabtagene vicleucel), by agreeing to acquire 2seventy bio for approximately ...
Just in time for the annual American Society of Clinical Oncology (ASCO) meeting in Chicago, Bristol Myers Squibb launched a campaign to highlight its progress in dual immuno-oncology (I-O) research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results